From: Improving reference prioritisation with PICO recognition
 | [120] | [121] | LR | PICO | Δ |
---|---|---|---|---|---|
ACE Inhibitors | 74.3 | *82.7 | 74.7 | 74.4 | -0.3 |
ADHD | 67.9 | *82.1 | 67.5 | 68.9 | 1.4 |
Antihistamines | *24.5 | 17.7 | -1.7 | -1.9 | -0.1 |
Atypical Antipsychotics | 18.0 | *33.6 | 18.0 | 20.5 | 2.5 |
Beta Blockers | 65.0 | *68.5 | 54.7 | 55.7 | 1.1 |
Calcium Channel Blockers | 17.3 | 12.8 | *47.6 | 47.1 | -0.5 |
Estrogens | 22.6 | 28.5 | 36.6 | *39.1 | 2.4 |
NSAIDS | *77.4 | 64.1 | 60.9 | 63.1 | 2.2 |
Opioids | 9.0 | 17.4 | 19.5 | *34.1 | 14.6 |
Oral Hypoglycemic | 13.5 | *15.9 | 6.9 | 9.2 | 2.3 |
Proton Pump Inhibitors | 19.7 | 21.0 | *21.2 | 18.3 | -2.9 |
Skeletal Muscle Relaxants | *58.6 | 29.9 | 25.9 | 32.4 | 6.5 |
Statins | 27.8 | *43.7 | 42.9 | 43.3 | 0.3 |
Triptans | 39.6 | *54.1 | 34.3 | 52.4 | 18.1 |
Urinary Incontinence | 20.8 | 41.6 | 44.8 | *46.4 | 1.6 |
Average | 37.1 | 40.9 | 36.9 | 40.2 | 3.3 |